RARE Operating Income - Ultragenyx Pharmaceutical Inc.

Complete source-backed operating income history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Operating Income

Date	Operating Income
2026-06-30	-$75M
2026-03-31	-$169M
2025-12-31	-$113.28M
2025-09-30	-$170.89M
2025-06-30	-$108M
2025-03-31	-$143M
2024-12-31	-$122.31M
2024-09-30	-$131.99M
2024-06-30	-$116.36M
2024-03-31	-$165.35M
2023-12-31	-$121.84M
2023-09-30	-$145.1M
2023-06-30	-$147.96M
2023-03-31	-$154.11M
2022-12-31	-$145.63M
2022-09-30	-$225.07M
2022-06-30	-$141.59M
2022-03-31	-$136.63M
2021-12-31	-$102.56M
2021-09-30	-$89.83M
2021-06-30	-$82.78M
2021-03-31	-$106.57M
2020-12-31	-$96.08M
2020-09-30	-$50.32M
2020-06-30	-$63.06M
2020-03-31	-$120.67M
2019-12-31	-$94.45M
2019-09-30	-$118.03M
2019-06-30	-$112.47M
2019-03-31	-$99.21M
2018-12-31	-$90.34M
2018-09-30	-$89.65M
2018-06-30	-$94.9M
2018-03-31	-$96.49M
2017-12-31	-$96.83M
2017-09-30	-$83.71M
2017-06-30	-$78.44M
2017-03-31	-$69.95M
2016-12-31	-$70.55M
2016-09-30	-$65.78M
2016-06-30	-$58.05M
2016-03-31	-$53.62M
2015-12-31	-$56.16M
2015-09-30	-$39.94M
2015-06-30	-$30.14M
2015-03-31	-$21.5M
2014-12-31	-$16.94M
2014-09-30	-$15.84M
2014-06-30	-$13.66M
2014-03-31	-$10.34M
2013-12-31	-$9.53M
2013-09-30	-$7.76M
2013-06-30	-$8.25M
2013-03-31	-$6.75M

Annual Operating Income

Date	Operating Income
2025-12-31	-$535M
2024-12-31	-$536M
2023-12-31	-$569M
2022-12-31	-$648.92M
2021-12-31	-$381.74M
2020-12-31	-$330.12M
2019-12-31	-$424.17M
2018-12-31	-$371.37M
2017-12-31	-$328.94M
2016-12-31	-$248.01M
2015-12-31	-$147.74M
2014-12-31	-$56.78M
2013-12-31	-$32.28M
2012-12-31	-$15.99M